Trends of Antihypertensive Prescription Among US Adults From 2010 to 2019 and Changes Following Treatment Guidelines: Analysis of Multicenter Electronic Health Records

Abstract

Background

Guidelines for the use of antihypertensives changed in 2014 and 2017. To understand the effect of these guidelines, we examined trends in antihypertensive prescriptions in the United States from 2010 to 2019 using a repeated cross‐sectional design.

Methods and Results

Using electronic health records from 15 health care institutions for adults (20–85 years old) who had ≥1 antihypertensive prescription, we assessed whether (1) prescriptions of beta blockers decreased after the 2014 Eighth Joint National Committee (JNC 8) report discouraged use for first‐line treatment, (2) prescriptions for calcium channel blockers and thiazide diuretics increased among Black patients after the JNC 8 report encouraged use as first‐line therapy, and (3) prescriptions for dual therapy and fixed‐dose combination among patients with blood pressure ≥140/90 mm Hg increased after recommendations in the 2017 Hypertension Clinical Practice Guidelines. The study included 1 074 314 patients with 2 133 158 prescription episodes. After publication of the JNC 8 report, prescriptions for beta blockers decreased (3% lower in 2018–2019 compared to 2010–2014), and calcium channel blockers increased among Black patients (20% higher in 2015–2017 and 41% higher in 2018–2019, compared to 2010–2014), in accordance with guideline recommendations. However, contrary to guidelines, dual therapy and fixed‐dose combination decreased after publication of the 2017 Hypertension Clinical Practice Guidelines (9% and 11% decrease in 2018–2019 for dual therapy and fixed‐dose combination, respectively, compared to 2015–2017), and thiazide diuretics decreased among Black patients after the JNC 8 report (6% lower in 2018–2019 compared to 2010–2014).

Conclusions

Adherence to guidelines on prescribing antihypertensive medication was inconsistent, presenting an opportunity for interventions to achieve better blood pressure control in the US population.